Hormonal control of plasminogen activator secretion in ZR-75-1 human breast cancer cells in culture.
Activity of secreted plasminogen activator (PA) by ZR-75-1 human breast cancer cells in culture is shown to be altered by the addition of physiologically relevant concentrations of the hormones 17 beta-estradiol (E2), insulin, and dexamethasone. After 48 h, E2 stimulated PA activity 6-fold at concentrations as low as 10(-12) M. This stimulation was prevented by the addition of actinomycin D and cycloheximide. The antiestrogen tamoxifen reduced estrogen stimulation of PA, but had slight stimulatory effects on PA secretion by itself. Insulin (5 X 10(-10) M) induced a 2-fold increase in PA activity. Effects of insulin and E2 were additive, suggesting independent sites of control of PA production. Dexamethasone (10(-8) M) decreased PA activity by 20%, but did not inhibit cell growth at the concentration tested. These data suggest that secreted PA activity is differentially regulated by hormones and that effects of PA and growth do not occur in parallel.
D001943:Breast Neoplasms / Q000378:metabolism*; D002478:Cells, Cultured; D003907:Dexamethasone / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007328:Insulin / Q000494:pharmacology*; D046911:Macromolecular Substances; D010960:Plasminogen Activators / Q000378:metabolism*; D013629:Tamoxifen / Q000494:pharmacology; D013936:Thymidine / Q000378:metabolism; D013997:Time Factors
D007328:Insulin; D046911:Macromolecular Substances; D013629:Tamoxifen; D004958:Estradiol; D003907:Dexamethasone; D010960:Plasminogen Activators; D013936:Thymidine